Evaluation of Midodrine Utilization in Patients with Cancer and Heart Failure.

Jorge A Irizarry-CaroJuhee SongChase MillerShyam DesaiJames GoingJose Fossas-EspinosaMariya M FatakdawalaAbdelrahman AliCezar IliescuNicolas PalaskasAnita DeswalEfstratios Koutroumpakis

Published in: Cardiovascular drugs and therapy (2024)

In our study, midodrine use in patients with cancer and HF was not associated with significant adverse effects, worse cardiovascular outcomes, or increased risk of mortality. Larger, prospective studies are needed to confirm these findings.

Keyphrases

heart failure
acute heart failure
left ventricular
risk factors
type diabetes
case control
cardiac resynchronization therapy